Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $464.00
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target boosted by investment analysts at Morgan Stanley from $462.00 to $464.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has an “equal weight” rating on the pharmaceutical company’s stock. Morgan Stanley’s target price would suggest a potential upside of 6.71% from the […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target boosted by investment analysts at Morgan Stanley from $462.00 to $464.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has an “equal weight” rating on the pharmaceutical company’s stock. Morgan Stanley’s target price would suggest a potential upside of 6.71% from the […]
